$TPHS
Trinity Place Holdings Inc. Stock $tphs

$tphs Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000155837023005313 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$14.73M	$10.27M	$42.98M
YoY Change	94.97%	-57.98%	51.45%
Cost Of Revenue	$1.730M	$1.795M	$5.877M
YoY Change	178.14%	-50.24%	-21.46%
Gross Profit	$13.00M	$8.479M	$37.11M
YoY Change	87.51%	-59.32%	83.03%
Gross Profit Margin	88.25%	82.53%	86.33%
Selling, General & Admin	$1.444M	$1.318M	$5.754M
YoY Change	26.78%	57.47%	28.09%
% of Gross Profit	11.11%	15.54%	15.51%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.892M	$1.881M	$6.471M
YoY Change	34.66%	114.73%	25.97%
% of Gross Profit	14.56%	22.18%	17.44%
Operating Expenses	$16.74M	$10.40M	$51.60M
YoY Change	82.06%	-56.96%	25.11%
Operating Profit	-$2.012M	-$1.917M	-$8.612M
YoY Change	22.61%	-42.14%	-33.03%
Interest Expense	-$6.328M	-$6.887M	-$15.70M
YoY Change	689.03%	964.45%	421.28%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$6.112M	-$8.967M	-$20.40M
YoY Change	147.65%	126.38%	16.67%
Income Tax	$124.0K	$16.00K	$288.0K
% Of Pretax Income
Net Earnings	-$6.236M	-$8.983M	-$20.69M
YoY Change	145.71%	117.03%	16.55%
Net Earnings / Revenue	-42.34%	-87.43%	-48.13%
Basic Earnings Per Share	-$0.17		-$0.56
Diluted Earnings Per Share	-$0.17	-$0.24	-$0.56
COMMON SHARES
Basic Shares Outstanding	37.16M	36.91M	37.22K
Diluted Shares Outstanding	37.61M		37.22K

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.582M	$1.548M	$1.548M
YoY Change	86.97%	-64.08%	-64.08%
Cash & Equivalents	$2.600M	$1.500M	$1.548M
Short-Term Investments
Other Short-Term Assets	$1.746M	$2.494M	$2.494M
YoY Change	5.24%	270.58%	270.58%
Inventory
Prepaid Expenses
Receivables	$261.0K	$262.0K	$262.0K
Other Receivables	$183.0K	$163.0K	$163.0K
Total Short-Term Assets	$4.772M	$4.467M	$4.467M
YoY Change	48.29%	-13.78%	-13.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$64.84M	$65.60M	$65.60M
YoY Change	-77.68%	-77.46%	-77.46%
Goodwill
YoY Change
Intangibles	$7.507M	$7.692M
YoY Change	-8.97%	-8.78%
Long-Term Investments	$0.00	$4.400M	$4.386M
YoY Change	-100.0%	-8.33%	-75.55%
Other Assets	$211.0M	$223.5M	$223.5M
YoY Change	1382.76%	988.41%	988.41%
Total Long-Term Assets	$284.5M	$302.5M	$302.5M
YoY Change	-15.03%	-11.41%	-11.41%
TOTAL ASSETS
Total Short-Term Assets	$4.772M	$4.467M	$4.467M
Total Long-Term Assets	$284.5M	$302.5M	$302.5M
Total Assets	$289.3M	$306.9M	$306.9M
YoY Change	-14.43%	-11.44%	-11.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$21.20M	$19.02M	$19.02M
YoY Change	6.67%	6.46%	6.46%
Accrued Expenses	$931.0K	$1.037M	$1.037M
YoY Change	-30.88%	-28.33%	-28.33%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$22.13M	$20.06M	$20.06M
YoY Change	4.28%	3.85%	3.85%
LONG-TERM LIABILITIES
Long-Term Debt	$245.3M	$258.8M	$258.8M
YoY Change	-6.53%	-4.4%	-4.4%
Other Long-Term Liabilities	$661.0K	$727.0K	$727.0K
YoY Change	-56.37%	-36.56%	-36.56%
Total Long-Term Liabilities	$246.0M	$259.5M	$259.5M
YoY Change	-6.82%	-4.53%	-4.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.13M	$20.06M	$20.06M
Total Long-Term Liabilities	$246.0M	$259.5M	$259.5M
Total Liabilities	$268.1M	$279.6M	$279.6M
YoY Change	-5.99%	-3.98%	-3.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.12M	-$56.89M
YoY Change	89.42%	84.78%
Common Stock	$145.4M	$145.3M
YoY Change	0.37%	0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.18M	$27.34M	$27.34M
YoY Change
Total Liabilities & Shareholders Equity	$289.3M	$306.9M	$306.9M
YoY Change	-14.43%	-11.44%	-11.44%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$6.236M	-$8.983M	-$20.69M
YoY Change	145.71%	117.03%	16.55%
Depreciation, Depletion And Amortization	$1.892M	$1.881M	$6.471M
YoY Change	34.66%	114.73%	25.97%
Cash From Operating Activities	$4.084M	-$5.477M	$1.351M
YoY Change	-759.77%	-6.85%	-118.15%
INVESTING ACTIVITIES
Capital Expenditures	$29.00K	$0.00	$93.00K
YoY Change	-100.62%	-100.0%	-100.26%
Acquisitions
YoY Change
Other Investing Activities	$7.240M	$0.00	$17.42M
YoY Change	28.51%	-100.0%	-21.8%
Cash From Investing Activities	$7.211M	$0.00	$17.33M
YoY Change	675.38%	-100.0%	-224.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$290.0K
YoY Change			-103.99%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-14.60M	15.86M	-21.47M
YoY Change	52.98%	488.72%	-171.19%
NET CHANGE
Cash From Operating Activities	4.084M	-5.477M	1.351M
Cash From Investing Activities	7.211M	0.000	17.33M
Cash From Financing Activities	-14.60M	15.86M	-21.47M
Net Change In Cash	-3.304M	10.38M	-2.790M
YoY Change	-64.21%	-14.87%	-131.79%
FREE CASH FLOW
Cash From Operating Activities	$4.084M	-$5.477M	$1.351M
Capital Expenditures	$29.00K	$0.00	$93.00K
Free Cash Flow	$4.055M	-$5.477M	$1.258M
YoY Change	-0.73%	1638.73%	-95.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#PensionAndOtherPostretirementBenefitExpense
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#PensionAndOtherPostretirementBenefitExpense
CY2021Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2022Q4	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	1
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000724742
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssets
CY2021Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#PrepaidExpenseAndOtherAssets
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost Credit Excluding Service Cost Statement Of Income Or Comprehensive Income Extensible List DefinedBenefitPlanNetPeriodicBenefitCostCreditExcludingServiceCostStatementOfIncomeOrComprehensiveIncomeExtensibleList	http://fasb.org/us-gaap/2022#PensionAndOtherPostretirementBenefitExpense
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-08546
CY2022	dei	Entity Registrant Name EntityRegistrantName	TRINITY PLACE HOLDINGS INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-2465228
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	340 Madison Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10173
CY2022	dei	City Area Code CityAreaCode	212
CY2022	dei	Local Phone Number LocalPhoneNumber	235-2190
CY2022	dei	Security12b Title Security12bTitle	Common Stock $0.01 Par Value Per Share
CY2022	dei	Trading Symbol TradingSymbol	TPHS
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	25710000
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37163137
CY2022	dei	Auditor Firm AuditorFirmId	243
CY2022	dei	Auditor Name AuditorName	BDO USA, LLP
CY2022	dei	Auditor Location AuditorLocation	New York, New York
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	64651000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67334000
CY2022Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	202999000
CY2021Q4	us-gaap	Real Estate Heldforsale RealEstateHeldforsale	216983000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1548000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20507000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3774000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4126000
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	4386000
CY2021Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	17938000
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	262000
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	84000
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	163000
CY2021Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	114000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	945000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1314000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7692000
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8432000
CY2022Q4	us-gaap	Assets Assets	306927000
CY2021Q4	us-gaap	Assets Assets	341170000
CY2022Q4	us-gaap	Loans Payable LoansPayable	208762000
CY2021Q4	us-gaap	Loans Payable LoansPayable	219249000
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	34429000
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	32844000
CY2022Q4	us-gaap	Secured Debt SecuredDebt	9750000
CY2021Q4	us-gaap	Secured Debt SecuredDebt	12750000
CY2022Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2021Q4	us-gaap	Notes Payable NotesPayable	5863000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	19018000
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	17864000
CY2022Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	651000
CY2021Q4	us-gaap	Defined Benefit Pension Plan Current And Noncurrent Liabilities DefinedBenefitPensionPlanCurrentAndNoncurrentLiabilities	0
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1037000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1447000
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	76000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1146000
CY2022Q4	us-gaap	Liabilities Liabilities	279586000
CY2021Q4	us-gaap	Liabilities Liabilities	291163000
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q4	tphs	Special Stock Value SpecialStockValue	0
CY2021Q4	tphs	Special Stock Value SpecialStockValue	0
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43448384
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36907862
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	435000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	430000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144879000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	144282000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6540522
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	6397875
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57461000
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	57166000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3626000
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1343000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-56886000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36196000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27341000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	306927000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	341170000
CY2022	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5502000
CY2021	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	3225000
CY2020	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	1563000
CY2022	us-gaap	Other Income OtherIncome	182000
CY2021	us-gaap	Other Income OtherIncome	355000
CY2020	us-gaap	Other Income OtherIncome	263000
CY2022	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	37300000
CY2021	tphs	Revenue From Sale Of Residential Condominium Units RevenueFromSaleOfResidentialCondominiumUnits	23685000
CY2022	us-gaap	Revenues Revenues	42984000
CY2021	us-gaap	Revenues Revenues	27265000
CY2020	us-gaap	Revenues Revenues	1826000
CY2022	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	4180000
CY2021	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	5583000
CY2020	tphs	Cost Of Property Operating Expenses CostOfPropertyOperatingExpenses	9120000
CY2022	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	1697000
CY2021	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	724000
CY2020	us-gaap	Real Estate Tax Expense RealEstateTaxExpense	254000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5754000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5133000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5217000
CY2022	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	548000
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	67000
CY2020	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	345000
CY2022	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	35236000
CY2021	tphs	Cost Of Sale Of Residential Condominium Units CostOfSaleOfResidentialCondominiumUnits	22370000
CY2022	us-gaap	Recapitalization Costs RecapitalizationCosts	163000
CY2020	us-gaap	Recapitalization Costs RecapitalizationCosts	133000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4018000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4003000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3907000
CY2022	us-gaap	Operating Expenses OperatingExpenses	51596000
CY2021	us-gaap	Operating Expenses OperatingExpenses	37880000
CY2020	us-gaap	Operating Expenses OperatingExpenses	18976000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-8612000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10615000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	7046000
CY2022	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	804000
CY2021	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	-555000
CY2020	tphs	Income Loss From Equity Method Investments Excluding Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsExcludingGainOnSaleOfProperty	-1571000
CY2022	tphs	Income Loss From Equity Method Investments Gain On Sale Of Property IncomeLossFromEquityMethodInvestmentsGainOnSaleOfProperty	4490000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1070000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-15701000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-7922000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1540000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2453000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1521000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	261000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20402000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20540000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4639000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	288000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20690000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20805000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4333000
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-2283000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	816000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	1015000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-22973000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19989000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5348000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37224
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33322
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32305
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37224
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33322
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32860
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55964000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4333000
CY2020	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-696000
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-1015000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1163000
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	359000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	62020000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20805000
CY2021	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-370000
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	-816000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	7639000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	707000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	50007000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20690000
CY2022	tphs	Shares Issued Value Settlement Of Stock Awards SharesIssuedValueSettlementOfStockAwards	-290000
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plan Net Prior Service Costs Credit Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax	2283000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	597000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	27341000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-20690000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-20805000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4333000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6471000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5524000
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4168000
CY2022	us-gaap	Paid In Kind Interest PaidInKindInterest	4651000
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	1850000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	553000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	530000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	806000
CY2020	tphs	Gain Loss On Sale Of School Condominium GainLossOnSaleOfSchoolCondominium	24196000
CY2022	tphs	Gain On Sale Of Joint Venture Real Estate GainOnSaleOfJointVentureRealEstate	4490000
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	49000
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	24000
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	84000
CY2021	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-816000
CY2020	tphs	Reduction Of Claims Liability ReductionOfClaimsLiability	-1015000
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1070000
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-73000
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-965000
CY2022	tphs	Income Loss From Equity Method Investments Cash Flow IncomeLossFromEquityMethodInvestmentsCashFlow	804000
CY2021	tphs	Income Loss From Equity Method Investments Cash Flow IncomeLossFromEquityMethodInvestmentsCashFlow	-555000
CY2020	tphs	Income Loss From Equity Method Investments Cash Flow IncomeLossFromEquityMethodInvestmentsCashFlow	-1571000
CY2022	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1428000
CY2021	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	885000
CY2020	tphs	Distribution Of Cumulative Earnings From Unconsolidated Joint Venture DistributionOfCumulativeEarningsFromUnconsolidatedJointVenture	1110000
CY2022	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	-15600000
CY2021	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	11450000
CY2020	us-gaap	Increase Decrease In Assets Held For Sale IncreaseDecreaseInAssetsHeldForSale	46473000
CY2022	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	178000
CY2021	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-882000
CY2020	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2392000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1783000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	257000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-190000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1712000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1617000
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1285000
CY2021	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1288000
CY2020	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	-1033000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1351000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21238000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55881000
CY2022	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	93000
CY2021	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	140000
CY2020	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	4279000
CY2020	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	5383000
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	17418000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	17325000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-140000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9662000
CY2022	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	30239000
CY2021	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	249984000
CY2020	tphs	Proceeds From Loans And Corporate Facility ProceedsFromLoansAndCorporateFacility	86361000
CY2022	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	500000
CY2021	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	8200000
CY2020	tphs	Proceeds From Loans And Line Of Credit ProceedsFromLoansAndLineOfCredit	5000000
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6552000
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1497000
CY2022	tphs	Repayments Of Loans RepaymentsOfLoans	48415000
CY2021	tphs	Repayments Of Loans RepaymentsOfLoans	225547000
CY2020	tphs	Repayments Of Loans RepaymentsOfLoans	23368000
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3500000
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	3200000
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	2500000
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	290000
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	370000
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	695000
CY2020	tphs	Proceeds From Stock Buy Back ProceedsFromStockBuyBack	359000
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7639000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21466000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	30154000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	62942000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2790000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8776000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2601000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22055000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9196000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9474000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18670000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1548000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4310000
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6515000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20507000
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20535000
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	9554000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22055000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24845000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16069000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	12711000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	16042000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	15495000
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	381000
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	395000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	251000
CY2022	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	1572000
CY2021	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	3193000
CY2020	tphs	Capitalized Amortization Of Deferred Financing Costs And Lease Commissions CapitalizedAmortizationOfDeferredFinancingCostsAndLeaseCommissions	2668000
CY2022	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	44000
CY2021	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	122000
CY2020	tphs	Capitalized Stock Based Compensation Expense CapitalizedStockBasedCompensationExpense	299000
CY2022	tphs	Unrealized Loss On Pension Liability UnrealizedLossOnPensionLiability	2283000
CY2021	tphs	Loan Forgiveness Non Cash LoanForgivenessNonCash	243000
CY2020	tphs	Noncash Investment In Unconsolidated Joint Venture NoncashInvestmentInUnconsolidatedJointVenture	5193000
CY2022	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">NOTE 1 – BASIS OF PRESENTATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">General Business Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Trinity Place Holdings Inc., which we refer to in these financial statements as “Trinity,” “we,” “our,” or “us,” is a real estate holding, investment, development and asset management company. Our largest asset is currently a property located at 77 Greenwich Street in Lower Manhattan (“77 Greenwich”), which is nearing completion as a mixed-use project consisting of a 90-unit residential condominium tower, retail space and a New York City elementary school. We also own a 105-unit, 12-story multi-family property located at 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> Street in Brooklyn, New York (“237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”), and, through a joint venture, a 10% interest in a 234-unit multi-family property at 250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup> street in Brooklyn, New York (“250 North 10<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>”) that we sold to our joint venture partner in February 2023, as well as a property occupied by a retail tenant in Paramus, New Jersey. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We also control a variety of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. (“Syms”), including FilenesBasement.com, our rights to the Stanley Blacker® brand, as well as the intellectual property associated with the Running of the Brides® event and An Educated Consumer is Our Best Customer® slogan. In addition, we had approximately $275.8 million of federal net operating loss carryforwards (“NOLs”) at December 31, 2022, which can be used to reduce our future taxable income and capital gains.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Square footage, leased occupancy percentage and residential unit disclosures in the notes to consolidated financial statements are unaudited.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Liquidity and Going Concern; Management’s Plans; Recent Developments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern, which contemplate the realization of assets and liquidation of liabilities in the normal course of business. The COVID-19 pandemic and related matters, including government actions, shifts in residential consumer sentiment and changes to the broader and local economies, had a significant adverse impact on our business. More recently, the economic downturn, increased interest rates and high inflation have also impacted our business. As of December 31, 2022, we had total cash and restricted cash of $22.1 million, of which approximately $1.5 million was cash and cash equivalents and approximately $20.5 million was restricted cash. We also had $2.0 million available under our secured line of credit at December 31, 2022, which has since been drawn. The Company’s cash and cash equivalents will not be sufficient to fund the Company’s operations, debt service, amortization and maturities and corporate expenses over the next 12 months, unless we are able to extend or refinance our maturing debt and raise additional capital, creating substantial doubt about our ability to continue as a going concern. Management is exploring opportunities to secure additional funding through the sale of assets, refinancings of outstanding indebtedness, and equity or debt financings or other sources. The Company also continues to explore a range of strategic and financing alternatives. Potential strategic alternatives that may be evaluated include securing an equity and/or debt financing of the Company, refinancing of existing debt, and/or a sale or merger or reverse merger of the Company. The Company is also in discussions with its lenders regarding the deferment of upcoming interest, amortization and other payment obligations for the period ending March 31, 2023 and going forward. The Company is also exploring a refinancing of the debt in respect of 237 11<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">th</sup>. Given the current environment there can be no assurance that we will be able to enter into any of the contemplated or future extensions, amendments or waivers with our lenders, raise additional capital, refinance indebtedness or enter into other financing arrangements or engage in asset sales or strategic partnerships sufficient to fund our cash needs, on terms satisfactory to us, if at all. Further, in the event that market conditions preclude our ability to consummate such transactions, we will be required to evaluate additional alternatives in restructuring our business and our capital structure, including but not limited to filing for bankruptcy protection or seeking an out-of-court restructuring of our liabilities. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:normal;font-weight:normal;">While construction at 77 Greenwich has taken longer than projected and the impact of the pandemic and broader economic conditions have impeded the sale of residential condominium units at 77 Greenwich, we continue to sign and close contracts for our residential condominium units, including </span><span style="font-style:normal;font-weight:normal;">five</span><span style="font-style:normal;font-weight:normal;"> units since December 31, 2022. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:normal;font-weight:normal;">The financial statements do not include any adjustments that might result from the outcome of any uncertainty as to our ability to continue as a going concern.</span></p>
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22100000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1500000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	20500000
CY2022Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2000000.0
CY2021Q4	tphs	Investments In Unconsolidated Joint Ventures Provision For Impairment InvestmentsInUnconsolidatedJointVenturesProvisionForImpairment	0
CY2022Q4	tphs	Investments In Unconsolidated Joint Ventures Provision For Impairment InvestmentsInUnconsolidatedJointVenturesProvisionForImpairment	0
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">c. <i style="font-style:italic;">Use of Estimates</i> - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, actual results could differ from those estimates (see Note 2g. for further discussion).</p>
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt 0pt 10pt 18pt;">e. <i style="font-style:italic;">Concentrations of Credit Risk</i> - Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents. We hold substantially all of our cash and cash equivalents in banks. Such cash balances at times exceed federally insured limits.</p>
CY2021Q4	tphs	Real Estate Held For Sale Provision For Impairment RealEstateHeldForSaleProvisionForImpairment	0
CY2022Q4	tphs	Real Estate Held For Sale Provision For Impairment RealEstateHeldForSaleProvisionForImpairment	0
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2021Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	51141000
CY2022Q4	us-gaap	Tenant Improvements TenantImprovements	221000
CY2021Q4	us-gaap	Tenant Improvements TenantImprovements	200000
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	847000
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	775000
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
CY2021Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	28847000
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	81056000
CY2021Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	80963000
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	16405000
CY2021Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	13629000
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	64651000
CY2021Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	67334000
CY2022	us-gaap	Depreciation Depreciation	4000000.0
CY2021	us-gaap	Depreciation Depreciation	4000000.0
CY2020	us-gaap	Depreciation Depreciation	3900000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	11100000
CY2022	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	3400000
CY2021	tphs	Intangible Assets Accumulated Amortization IntangibleAssetsAccumulatedAmortization	2700000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	740000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3992000
CY2022Q4	tphs	Aggregate Fees Paid By Sca To Company AggregateFeesPaidByScaToCompany	46300000
CY2022Q4	tphs	Remaining Fees To Be Paid By Sca To Company RemainingFeesToBePaidByScaToCompany	243000
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2494000
CY2021Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	673000
CY2022Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2021Q4	tphs	Deferred Finance Costs DeferredFinanceCosts	2184000
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	1066000
CY2021Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	2736000
CY2022Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	5744000
CY2021Q4	tphs	Prepaid Expense And Other Assets Gross PrepaidExpenseAndOtherAssetsGross	5593000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1970000
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1467000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3774000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4126000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	288000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	265000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	306000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	288000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	265000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	306000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	288000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	306000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.136
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.167
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.063
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.001
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.050
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.360
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.385
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.278
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.015
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.011
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.045
CY2022Q4	tphs	Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6000
CY2021Q4	tphs	Deferred Tax Liabilities Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxLiabilitiesTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	74313000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66851000
CY2022Q4	tphs	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciation	5717000
CY2021Q4	tphs	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Depreciation DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDepreciation	5737000
CY2022Q4	tphs	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	359000
CY2021Q4	tphs	Deferred Tax Assets Tax Deferred Lease Liability DeferredTaxAssetsTaxDeferredLeaseLiability	507000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	212000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	256000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	225000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Pensions DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions	0
CY2022Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	448000
CY2021Q4	us-gaap	Deferred Tax Assets Investments DeferredTaxAssetsInvestments	777000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	356000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	332000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	81636000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	74461000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78285000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70134000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3351000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4327000
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2706000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	2220000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	7819000
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3003000
CY2022Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	261000
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	253000
CY2022Q4	tphs	Deferred Tax Liabilities Pension Cost DeferredTaxLiabilitiesPensionCost	0
CY2021Q4	tphs	Deferred Tax Liabilities Pension Cost DeferredTaxLiabilitiesPensionCost	571000
CY2022Q4	tphs	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	384000
CY2021Q4	tphs	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	500000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	3351000
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	4327000
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	tphs	Deferred Tax Asset Net Current DeferredTaxAssetNetCurrent	0
CY2021	tphs	Deferred Tax Asset Net Current DeferredTaxAssetNetCurrent	0
CY2022	tphs	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	0
CY2021	tphs	Deferred Tax Asset Net Noncurrent DeferredTaxAssetNetNoncurrent	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022	us-gaap	Tax Credit Carryforward Limitations On Use TaxCreditCarryforwardLimitationsOnUse	Pursuant to the tax legislation known as the Tax Cuts and Jobs Act (the "TCJA") of 2017, corporate alternative minimum tax (“AMT”) credit carryforwards are eligible for a 50% refund in tax years 2018 through 2020
CY2019Q4	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1600000
CY2020Q3	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	1500000
CY2022Q4	tphs	Federal Net Operating Loss Carryforwards Utilized To Date FederalNetOperatingLossCarryforwardsUtilizedToDate	20100000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	78300000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70100000
CY2022	tphs	Number Of Retail Lease Signed Expires NumberOfRetailLeaseSignedExpires	1
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	3372000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	831000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	467000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	484000
CY2022Q4	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	445000
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	12600000
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14308000
CY2020Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14224000
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	694000
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	665000
CY2022	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	-888000
CY2021	us-gaap	Defined Benefit Plan Actuarial Gain Loss DefinedBenefitPlanActuarialGainLoss	344000
CY2022	tphs	Defined Benefit Plan Benefits Received Paid DefinedBenefitPlanBenefitsReceivedPaid	-846000
CY2021	tphs	Defined Benefit Plan Benefits Received Paid DefinedBenefitPlanBenefitsReceivedPaid	-925000
CY2022Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	13268000
CY2021Q4	us-gaap	Defined Benefit Plan Benefit Obligation DefinedBenefitPlanBenefitObligation	14308000
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15940000
CY2020Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	14568000
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	400000
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	400000
CY2022	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	846000
CY2021	us-gaap	Defined Benefit Plan Benefit Obligation Benefits Paid DefinedBenefitPlanBenefitObligationBenefitsPaid	925000
CY2022	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	-2877000
CY2021	us-gaap	Defined Benefit Plan Actual Return On Plan Assets DefinedBenefitPlanActualReturnOnPlanAssets	1897000
CY2022Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	12617000
CY2021Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	15940000
CY2022Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-651000
CY2021Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	1632000
CY2022	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	694000
CY2021	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	665000
CY2020	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	658000
CY2022	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-953000
CY2021	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-842000
CY2020	tphs	Defined Benefit Plan Gain Loss On Plan Assets DefinedBenefitPlanGainLossOnPlanAssets	-758000
CY2021	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-105000
CY2020	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	-247000
CY2022	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-259000
CY2021	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	-72000
CY2020	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	147000
CY2022Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2021Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2020Q4	us-gaap	Defined Benefit Plan Assumptions Used Calculating Benefit Obligation Discount Rate DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate	0.050
CY2022	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2021	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2020	us-gaap	Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Rate Of Compensation Increase DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease	0.000
CY2020	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2021	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2022	tphs	Expected Long Term Rate Of Return ExpectedLongTermRateOfReturn	0.06
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths	1078000
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Two DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo	1069000
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Three DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree	1072000
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Four DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour	1061000
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Year Five DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive	1061000
CY2022Q4	us-gaap	Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter	4147000
CY2022	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	61000
CY2021	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	69000
CY2020	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	71000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	470000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	470000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	116000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1056000
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1037000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	226429000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	35750000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	262179000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3375000
CY2022Q4	us-gaap	Notes And Loans Payable NotesAndLoansPayable	258804000
CY2022	us-gaap	Interest Costs Incurred InterestCostsIncurred	20616000
CY2021	us-gaap	Interest Costs Incurred InterestCostsIncurred	21238000
CY2020	us-gaap	Interest Costs Incurred InterestCostsIncurred	17174000
CY2022	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	4915000
CY2021	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	13314000
CY2020	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	15577000
CY2021	us-gaap	Interest Income Other InterestIncomeOther	2000
CY2020	us-gaap	Interest Income Other InterestIncomeOther	57000
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-15701000
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-7922000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1540000
CY2022Q4	tphs	Capital Stock Shares Authorized CapitalStockSharesAuthorized	120000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	79999997
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2022Q4	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	1
CY2021Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q4	tphs	Excess Stock Par Or Stated Value Per Share ExcessStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43448384
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43024424
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36907862
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	36626549
CY2019Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P10Y
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	7179000
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.50
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	4.31
CY2019Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2019Q4	tphs	Warrant Agreement Threshold Maximum Percentage Of Issued And Outstanding Common Stock After Exercise Of Warrants WarrantAgreementThresholdMaximumPercentageOfIssuedAndOutstandingCommonStockAfterExerciseOfWarrants	0.199
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	76000
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1100000
CY2022	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	1000000.0
CY2021	tphs	Unrealized Gain Loss On Warrants UnrealizedGainLossOnWarrants	73000
CY2022Q4	tphs	Warrant Holder S Right Number Of Board Members To Appoint WarrantHolderSRightNumberOfBoardMembersToAppoint	1
CY2022	tphs	Warrant Agreement Preemptive Rights Period WarrantAgreementPreemptiveRightsPeriod	P5Y
CY2022Q4	tphs	Warrant Agreement Threshold Minimum Beneficial Ownership Percentage WarrantAgreementThresholdMinimumBeneficialOwnershipPercentage	0.05
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	2650000
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.90
CY2019Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000.0
CY2020	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	250197
CY2020	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	483361
CY2020	tphs	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	1.93
CY2022Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	4500000
CY2021	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2021Q4	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2022Q4	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2022Q4	tphs	Special Stock Shares Authorized SpecialStockSharesAuthorized	1
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	548370
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2022	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1500000
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Value Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardValueOfAdditionalSharesAuthorized	0
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	152217
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.25
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	107754
CY2021	us-gaap	Deferred Compensation Arrangement With Individual Exercise Price DeferredCompensationArrangementWithIndividualExercisePrice	1.77
CY2022	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployee	60500
CY2022	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue	1.68
CY2021	tphs	Share Based Compensation Arrangement By Share Based Payment Award Forfeitures By Former Employee Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardForfeituresByFormerEmployeeWeightedAverageGrantDateFairValue	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1057824
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1569449
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	551083
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	469000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	333500
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.84
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	310000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	296084
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.22
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	227917
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	60500
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.68
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	527999
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.80
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	551083
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	2.14
CY2022Q4	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	437170
CY2021Q4	tphs	Deferred Compensation Arrangement With Individual Shares Outstanding DeferredCompensationArrangementWithIndividualSharesOutstanding	284913
CY2022	tphs	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List Not Disclosed Flag DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleListNotDisclosedFlag	true
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	4400000
CY2022Q4	tphs	Investment In Joint Venture Fair Value Of Derivative Liability InvestmentInJointVentureFairValueOfDerivativeLiability	77000
CY2021Q4	tphs	Investment In Joint Venture Fair Value Of Derivative Liability InvestmentInJointVentureFairValueOfDerivativeLiability	-77000
CY2022Q4	srt	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	69400000
CY2022Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	28847000
CY2022Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	45824000
CY2022	tphs	Realestate And Accumulated Depreciation Buildings And Improvements RealestateAndAccumulatedDepreciationBuildingsAndImprovements	6385000
CY2022Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	28847000
CY2022Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	52209000
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	81056000
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	16405000
CY2022Q4	tphs	Deferred Offering Costs Net DeferredOfferingCostsNet	350000
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	80963000
CY2020Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	80908000
CY2022	us-gaap	Real Estate Acquisitions Through Foreclosures RealEstateAcquisitionsThroughForeclosures	93000
CY2021	us-gaap	Real Estate Acquisitions Through Foreclosures RealEstateAcquisitionsThroughForeclosures	55000
CY2022Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	81056000
CY2021Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	80963000
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	13629000
CY2020Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	10868000
CY2022	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	2776000
CY2021	us-gaap	Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense	2761000
CY2022Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	16405000
CY2021Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	13629000

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001558370-23-005313-index-headers.html	Edgar Link	pending
0001558370-23-005313-index.html	Edgar Link	pending
0001558370-23-005313.txt	Edgar Link	pending
0001558370-23-005313-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tphs-20221231.xsd	Edgar Link	pending
tphs-20221231x10k.htm	Edgar Link	pending
tphs-20221231xex10d17.htm	Edgar Link	pending
tphs-20221231xex10d23.htm	Edgar Link	pending
tphs-20221231xex10d27.htm	Edgar Link	pending
tphs-20221231xex21d1.htm	Edgar Link	pending
tphs-20221231xex23d1.htm	Edgar Link	pending
tphs-20221231xex31d1.htm	Edgar Link	pending
tphs-20221231xex31d2.htm	Edgar Link	pending
tphs-20221231xex32d1.htm	Edgar Link	pending
tphs-20221231xex32d2.htm	Edgar Link	pending
tphs-20221231_def.xml	Edgar Link	unprocessable
tphs-20221231_lab.xml	Edgar Link	unprocessable
tphs-20221231_pre.xml	Edgar Link	unprocessable
tphs-20221231_cal.xml	Edgar Link	unprocessable
tphs-20221231x10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TPHS
Trinity Place Holdings Inc. Stock $tphs

2023 Q1 Form 10-K Financial Statement

#000155837023005313 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS Trinity Place Holdings Inc. Stock $tphs

2023 Q1 Form 10-K Financial Statement

#000155837023005313 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TPHS
Trinity Place Holdings Inc. Stock $tphs